treatment: be important for those with ptsd

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents regimen
Weight: 0.66
, surgery
Weight: 0.62
, protocol
Weight: 0.59
, matter
Weight: 0.58
Siblings gene therapy
Weight: 0.72
, dialysis
Weight: 0.70
, blood transfusion
Weight: 0.70
, aspirin
Weight: 0.67

Related properties

Property Similarity
be important for those with ptsd 1.00
be important for those 0.99
be important having 0.81
be important among things 0.81
be different from other nsaids 0.81
be around all us 0.81
be needed for people 0.81
be important to us 0.80
be important among living things 0.79
be found in three different states 0.78

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.42
Rule weight: 0.66
Evidence weight: 0.82
Similarity weight: 0.78
Evidence: 0.80
Plausible(matter, be found in three different states)
Evidence: 0.91
¬ Typical(treatment, be important for those with ptsd)

Plausibility inheritance from parent to child

0.07
Rule weight: 0.09
Evidence weight: 0.90
Similarity weight: 0.78
Evidence: 0.88
Plausible(treatment, be important for those with ptsd)
Evidence: 0.80
¬ Plausible(matter, be found in three different states)

Remarkability exclusitivity betweem a parent and a child

0.31
Rule weight: 0.58
Evidence weight: 0.69
Similarity weight: 0.78
Evidence: 0.70
¬ Remarkable(treatment, be important for those with ptsd)
Evidence: 0.44
¬ Remarkable(matter, be found in three different states)

Remarkability exclusitivity between siblings

0.07
Rule weight: 0.13
Evidence weight: 0.65
Similarity weight: 0.81
Evidence: 0.70
¬ Remarkable(treatment, be important for those with ptsd)
Evidence: 0.50
¬ Remarkable(aspirin, be different from other nsaids)
0.05
Rule weight: 0.13
Evidence weight: 0.47
Similarity weight: 0.81
Evidence: 0.70
¬ Remarkable(treatment, be important for those with ptsd)
Evidence: 0.76
¬ Remarkable(blood transfusion, be needed for people)

Remarkability from parent implausibility

0.31
Rule weight: 0.42
Evidence weight: 0.95
Similarity weight: 0.78
Evidence: 0.80
Plausible(matter, be found in three different states)
Evidence: 0.70
Remarkable(treatment, be important for those with ptsd)
Evidence: 0.88
¬ Plausible(treatment, be important for those with ptsd)

Remarkability from sibling implausibility

0.47
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.81
Evidence: 0.88
Plausible(treatment, be important for those with ptsd)
Evidence: 0.76
Remarkable(blood transfusion, be needed for people)
Evidence: 0.80
¬ Plausible(blood transfusion, be needed for people)
0.46
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 0.81
Evidence: 0.88
Plausible(treatment, be important for those with ptsd)
Evidence: 0.50
Remarkable(aspirin, be different from other nsaids)
Evidence: 0.89
¬ Plausible(aspirin, be different from other nsaids)

Salient implies Plausible

0.25
Rule weight: 0.28
Evidence weight: 0.89
Similarity weight: 1.00
Evidence: 0.88
Plausible(treatment, be important for those with ptsd)
Evidence: 0.96
¬ Salient(treatment, be important for those with ptsd)

Similarity expansion

0.81
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.99
Evidence: 0.96
Salient(treatment, be important for those with ptsd)
Evidence: 0.95
¬ Salient(treatment, be important for those)
0.78
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.99
Evidence: 0.91
Typical(treatment, be important for those with ptsd)
Evidence: 0.86
¬ Typical(treatment, be important for those)
0.76
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.99
Evidence: 0.88
Plausible(treatment, be important for those with ptsd)
Evidence: 0.86
¬ Plausible(treatment, be important for those)
0.65
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.99
Evidence: 0.70
Remarkable(treatment, be important for those with ptsd)
Evidence: 0.75
¬ Remarkable(treatment, be important for those)

Typical and Remarkable implies Salient

0.14
Rule weight: 0.14
Evidence weight: 0.97
Similarity weight: 1.00
Evidence: 0.96
Salient(treatment, be important for those with ptsd)
Evidence: 0.91
¬ Typical(treatment, be important for those with ptsd)
Evidence: 0.70
¬ Remarkable(treatment, be important for those with ptsd)

Typical implies Plausible

0.43
Rule weight: 0.48
Evidence weight: 0.89
Similarity weight: 1.00
Evidence: 0.88
Plausible(treatment, be important for those with ptsd)
Evidence: 0.91
¬ Typical(treatment, be important for those with ptsd)

Typicality and Rermarkability incompatibility between a parent and a child

0.14
Rule weight: 0.51
Evidence weight: 0.36
Similarity weight: 0.78
Evidence: 0.70
¬ Remarkable(treatment, be important for those with ptsd)
Evidence: 0.92
¬ Typical(matter, be found in three different states)

Typicality and Rermarkability incompatibility between siblings

0.05
Rule weight: 0.14
Evidence weight: 0.45
Similarity weight: 0.81
Evidence: 0.70
¬ Remarkable(treatment, be important for those with ptsd)
Evidence: 0.79
¬ Typical(blood transfusion, be needed for people)
0.04
Rule weight: 0.14
Evidence weight: 0.33
Similarity weight: 0.81
Evidence: 0.70
¬ Remarkable(treatment, be important for those with ptsd)
Evidence: 0.96
¬ Typical(aspirin, be different from other nsaids)

Typicality inheritance from parent to child

0.34
Rule weight: 0.48
Evidence weight: 0.91
Similarity weight: 0.78
Evidence: 0.91
Typical(treatment, be important for those with ptsd)
Evidence: 0.92
¬ Typical(matter, be found in three different states)